Recruiting ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis NCT07294170 Conditions AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more Locations Profound Research LLC - Carlsbad — Carlsbad, California, United States Visionary Investigators Network — Miami, Florida, United States University of South Florida — Tampa, Florida, United States Erlanger Health System — Columbia, Maryland, United States View all 29 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod NCT07284420 Conditions AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more Locations Profound Research LLC - Carlsbad — Carlsbad, California, United States Visionary Investigators Network — Miami, Florida, United States University of South Florida — Tampa, Florida, United States Henry Ford Health Systems — Detroit, Michigan, United States View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis NCT07673627 Conditions AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more Locations Visionary Investigators Network — Miami, Florida, United States Erlanger Health System — Chattanooga, Tennessee, United States View Trial Details
